The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative trial in high risk localized prostate cancer (PC).
 
Laura Graham
No Relationships to Disclose
 
Nicholas Reder
No Relationships to Disclose
 
Roman Gulati
No Relationships to Disclose
 
Petros Grivas
Consulting or Advisory Role - AstraZeneca; Biocept; Bristol-Myers Squibb; Clovis Oncology; Driver, Inc; EMD Serono; Foundation Medicine; Genentech; HERON; Janssen; Merck; Pfizer; QED Therapeutics; Seagen
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); Mirati Therapeutics (Inst); Oncogenex (Inst); Pfizer (Inst)
 
Jonathan L. Wright
Speakers' Bureau - Foundation Health Partners J. Michael Carroll Cancer Center; OncLive; seattle cancer care alliance
Research Funding - Altor BioScience; Merck; Nucleix
Other Relationship - Movember Foundation; UpToDate
 
Evan Y. Yu
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Churchill Pharmaceuticals; Dendreon; EMD Serono; Incyte; Janssen; Merck; QED Therapeutics; Seagen; Tolmar
Research Funding - Agensys (Inst); Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Genentech/Roche (Inst); Merck (Inst); Seagen (Inst)
 
Wendy Hou
No Relationships to Disclose
 
Katie Nega
No Relationships to Disclose
 
Todd Yezefski
No Relationships to Disclose
 
Robert B. Montgomery
Research Funding - AstraZeneca; ESSA; Ferring; Janssen Oncology
 
Elahe A. Mostaghel
Research Funding - Context Therapeutics (Inst)
 
William J. Ellis
Research Funding - Progenics
 
Lawrence D. True
Stock and Other Ownership Interests - Lightspeed Microscopy
Research Funding - Ventana Medical Systems
Patents, Royalties, Other Intellectual Property - Lens on an open-top lightsheet microscope
 
Daniel W. Lin
Consulting or Advisory Role - Astellas Pharma; Clovis Oncology; Dendreon
Research Funding - GenomeDx (Inst); Genomic Health (Inst); MDxHealth (Inst)
 
Peter Nelson
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology; Roche/Genentech
Expert Testimony - Venable
Travel, Accommodations, Expenses - Janssen Oncology
 
Michael Thomas Schweizer
Consulting or Advisory Role - Janssen
Research Funding - AstraZeneca (Inst); Janssen (Inst); Madison Vaccines, Inc. (Inst); Pfizer (Inst); Roche (Inst); Zenith Epigenetics (Inst)